Lixin Shao

1.9k citations

21 papers · 775 indexed · h-index 11

Co-authors: Thomas G. O’Riordan A. Bruce Montgomery Mauricio Tohen Robert W. Baker Ganesh Raghu Kevin R. Flaherty James J. Egan Fernando J. Martínez
Topics: Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (6 papers)Pulmonary Hypertension Research and Treatments (4 papers)Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers)
Cited by: Pulmonary and Respiratory Medicine Psychiatry and Mental health Speech and Hearing
Journals: Blood PLoS ONE Cancer Research
Partner nations: United States Australia United Kingdom

In The Last Decade

Lixin Shao

18 papers receiving 758 citations

Peers

Countries citing papers authored by Lixin Shao

Since Specialization

Citations

This map shows the geographic impact of Lixin Shao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lixin Shao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lixin Shao more than expected).

Fields of papers citing papers by Lixin Shao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lixin Shao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lixin Shao. The network helps show where Lixin Shao may publish in the future.

Co-authorship network of co-authors of Lixin Shao

This figure shows the co-authorship network connecting the top 25 collaborators of Lixin Shao. A scholar is included among the top collaborators of Lixin Shao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lixin Shao. Lixin Shao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Roles of FEN1 in tumor biology: Mechanisms, therapeutic implications, and emerging strategies 2025 ·Critical Reviews in Oncology/Hematology ·Yang Zhang,(unknown),Lixin Shao,Heng Yu,(unknown),(unknown),(unknown),(unknown),Xin Xing	0
2	Development and validation of a predictive 6-min walk score in patients with idiopathic pulmonary fibrosis 2025 ·European Respiratory Journal ·Steven D. Nathan,Jie Gao,Ho Cheol Kim,Abhimanyu Chandel,Henry Chen,Xiaomin Lu,(unknown),Lixin Shao,Timothy R. Watkins,Toby M. Maher,Lisa Lancaster	0
3	Derivation and validation of a noninvasive prediction tool to identify pulmonary hypertension in patients with IPF: Evolution of the model FORD 2023 ·The Journal of Heart and Lung Transplantation ·Steven D. Nathan,Abhimanyu Chandel,Ya Wang,(unknown),Lixin Shao,Timothy R. Watkins,(unknown),Christopher S. King,(unknown)	12
4	Congestion and Timing Aware Macro Placement Using Machine Learning Predictions from Different Data Sources 2022 ·Xiang Gao,Yimin Jiang,Lixin Shao,(unknown),(unknown),Manish Sharma,(unknown),(unknown)	7
5	A phase 2 study of momelotinib, a potent JAK1 and JAK2 inhibitor, in patients with polycythemia vera or essential thrombocythemia 2017 ·Leukemia Research ·Srđan Verstovšek,(unknown),Martin Grießhammer,Ruben A. Mesa,Carrie Baker Brachmann,Jun Kawashima,Julia D. Maltzman,Lixin Shao,Yan Xin,(unknown),Ashish Bajel	28
6	The Relative Bioavailability, Food Effect, and Drug Interaction With Omeprazole of Momelotinib Tablet Formulation in Healthy Subjects 2017 ·Clinical Pharmacology in Drug Development ·Xin Yan,Lixin Shao,(unknown),Dimitrios Stefanidis,(unknown),Thomas Tarnowski,Wei Deng,Jeffrey A. Silverman	8
7	Pharmacokinetics, Pharmacodynamics, and Safety of Entospletinib, a Novel pSYK Inhibitor, Following Single and Multiple Oral Dosing in Healthy Volunteers 2016 ·Clinical Drug Investigation ·Srini Ramanathan,Julie A. Di Paolo,Feng Jin,Lixin Shao,(unknown),(unknown),Brian P. Kearney	19
8	Correlation between T2* (T2 star) relaxation time and cervical intervertebral disc degeneration 2016 ·Medicine ·(unknown),Yong Guo,Qiong Ye,Lei Chen,Kai Zhou,Qingjun Wang,Lixin Shao,Qinglei Shi,(unknown)	13
9	Pulmonary hypertension in idiopathic pulmonary fibrosis with mild-to-moderate restriction 2015 ·European Respiratory Journal ·Ganesh Raghu,Steven D. Nathan,Jürgen Behr,Kevin K. Brown,James J. Egan,Steven M. Kawut,Kevin R. Flaherty,Fernando J. Martínez,Athol U. Wells,Lixin Shao,Huafeng Zhou,Noreen Henig,Javier Szwarcberg,Hunter Gillies,A. Bruce Montgomery,Thomas G. O’Riordan	105
10	Aztreonam for inhalation solution in patients with non-cystic fibrosis bronchiectasis (AIR-BX1 and AIR-BX2): two randomised double-blind, placebo-controlled phase 3 trials 2014 ·The Lancet Respiratory Medicine ·Alan F. Barker,Anne E. O’Donnell,Patrick A. Flume,Philip J. Thompson,(unknown),Javier de Gracia,Wim Boersma,Anthony De Soyza,Lixin Shao,Jenny Zhang,(unknown),Sandra A. Lewis,(unknown),A. Bruce Montgomery,Matthew McKevitt,David Gossage,Alexandra L. Quittner,Thomas G. O’Riordan	153
11	Diagnosis of idiopathic pulmonary fibrosis with high-resolution CT in patients with little or no radiological evidence of honeycombing: secondary analysis of a randomised, controlled trial 2014 ·The Lancet Respiratory Medicine ·Ganesh Raghu,David A. Lynch,J. David Godwin,(unknown),Thomas V. Colby,Kevin O. Leslie,Jürgen Behr,Kevin M. Brown,James J. Egan,Kevin R. Flaherty,Fernando J. Martínez,Athol U. Wells,Lixin Shao,Huafeng Zhou,(unknown),Rohit Sood,A. Bruce Montgomery,Thomas G. O’Riordan	136
12	Quantitative T2 Magnetic Resonance Imaging Compared to Morphological Grading of the Early Cervical Intervertebral Disc Degeneration: An Evaluation Approach in Asymptomatic Young Adults 2014 ·PLoS ONE ·Chun Chen,(unknown),Zhihua Han,Lixin Shao,Yan Xie,Jian Wu,Yan Zhang,(unknown),(unknown),Yong Guo,Deli Wang,Qing He,Dike Ruan	33
13	Two phase 3 placebo-controlled trials of aztreonam lysine for inhalation (AZLI) for non-cystic fibrosis bronchiectasis (NCFB) 2013 ·European Respiratory Journal ·Alan R. Barker,Anne O’Donnell,Philip J. Thompson,Patrick A. Flume,(unknown),Javier de Gracia,Wim Boersma,Eva Polverino,Lixin Shao,Jenny Zhang,(unknown),(unknown),Matt McKevitt,A. Bruce Montgomery,Alexandra L. Quittner,David Gossage,Thomas G. O’Riordan	10
14	Serum lysyl oxidase-like 2 levels and idiopathic pulmonary fibrosis disease progression 2013 ·European Respiratory Journal ·Jason W. Chien,Thomas J. Richards,Kevin F. Gibson,Yingze Zhang,Kathleen O. Lindell,Lixin Shao,Susan K. Lyman,Joanne I. Adamkewicz,Victoria Smith,Naftali Kaminski,Thomas G. O’Riordan	116
15	Abstract 26: Evaluation of the safety, pharmacokinetics and pharmacodynamics of GS-9973, a novel SYK inhibitor, and GS-1101, a novel PI3Kδ inhibitor, when administered alone or in combination in humans. 2013 ·Cancer Research ·(unknown),Julie A. Di Paolo,Lixin Shao,Ori Yellin,Michael Hawkins,S. Ramanathan	1
16	Dose-Response Analyses Of Momelotinib (CYT387), a JAK1 and JAK2 Inhibitor, From a Phase I/II Study (CCL09101) In Treatment Of Myelofibrosis 2013 ·Blood ·Xin Yan,Lixin Shao,Wei Deng,(unknown),Mark Kowalski,Linda M. Bavisotto,Jun Kawashima,Susie Jun,Helen Collins,S. Ramanathan	5
17	Elevated serum LOXL2 levels are associated with rapid disease progression in idiopathic pulmonary fibrosis (IPF) 2012 ·Jason W. Chien,Lixin Shao,Susan K. Lyman,Joanne I. Adamkewicz,Victoria Smith,Thomas G. O’Riordan	2
18	Acute Dysphoric Mania: Treatment Response to Olanzapine Versus Placebo 2003 ·Journal of Clinical Psychopharmacology ·Robert W. Baker,Mauricio Tohen,Jan Fawcett,Richard C. Risser,Leslie M. Schuh,Eileen Brown,Virginia L. Stauffer,Lixin Shao,Gary D. Tollefson	50
19	Rates of response, euthymia and remission in two placebo‐controlled olanzapine trials for bipolar mania 2003 ·Bipolar Disorders ·KN Roy Chengappa,Robert W. Baker,Lixin Shao,Lakshmi N. Yatham,Mauricio Tohen,Samuel Gershon,David J. Kupfer	70
20	Nietzsche in China 1999 ·Medical Entomology and Zoology ·Lixin Shao	1

About Lixin Shao

Lixin Shao is a scholar working on Genetics, Pulmonary and Respiratory Medicine and Hematology, having authored 21 papers that have together received 775 indexed citations. Recurring topics across this work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (6 papers), Pulmonary Hypertension Research and Treatments (4 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (499 citations), Psychiatry and Mental health (122 citations) and Speech and Hearing (37 citations). Lixin Shao has collaborated with scholars based in United States, Australia and United Kingdom. Frequent co-authors include Thomas G. O’Riordan, A. Bruce Montgomery, Mauricio Tohen, Robert W. Baker, Ganesh Raghu, Kevin R. Flaherty, James J. Egan, Fernando J. Martínez, Athol U. Wells and Huafeng Zhou. Their work appears in journals such as Blood, PLoS ONE and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact